Contact A Lawyer
Have A Potential Case Reviewed By An Attorney
An agreement was reached earlier this month to settle Risperdal lawsuits filed on behalf of five boys who alleged that they experienced unnatural male breast growth after taking the atypical antipsychotic.
The Risperdal settlements were finalized on October 4, in Philadelphia Court of Common Pleas, according to a report by Bloomberg News. However, no details have been made available about the amount of compensation paid for the male breast growth problems with Risperdal.
Johnson & Johnson faces about 100 product liability lawsuits over Risperdal breast growth side effects among boys. All of the complaints involves similar allegations that the drug maker failed to adequately research the medication or warn about the risk of breast growth among teen boys taking the antipsychotic.
In early September, it was reported that Johnson & Johnson settled a Risperdal breast growth lawsuit brought by a 21 year old, who alleged that the side effects caused him to suffer psychological trauma and undergo surgery to have the breasts removed. That settlement was reached before trial was to begin in the case, which was the first bellwether case scheduled to reach a jury.
Side effects of Risperdal have also been linked to an increased risk of significant weight gain, and in many cases doctors initially miss or dismiss signs of male breast growth, assuming it is connected to increases in weight. However, surgical breast removal or reduction may be necessary in some cases due to the unnatural growth.